CryoCell International Inc Cash Flow Conversion Efficiency
CryoCell International Inc cash flow conversion efficiency. Based on the latest financial reports, CryoCell International Inc (CCEL) has a cash flow conversion efficiency ratio of -0.171x as of August 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.54 Million) by net assets ($-14.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of CryoCell International Inc (1996–2024)
Cash flow conversion efficiency of CryoCell International Inc from 1996 to 2024. This chart illustrates how CryoCell International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CCEL share price today for real-time trading data and today's change.
CryoCell International Inc Cash Flow Conversion Ratio Explained
CryoCell International Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
CryoCell International Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CryoCell International Inc ranked by their cash flow conversion efficiency. Also see CCEL company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hudson Acquisition I Corp. Common Stock
NASDAQ:HUDA
|
0.012x |
|
Panagene Inc
KQ:046210
|
0.001x |
|
Century Lithium Corp.
V:LCE
|
-0.005x |
|
Zoomd Technologies Ltd
V:ZOMD
|
-0.016x |
|
Midland Exploration Inc
V:MD
|
-0.018x |
|
Kriti Industries (India) Limited
NSE:KRITI
|
-0.022x |
|
Siab Holdings Bhd
KLSE:0241
|
0.563x |
|
PolTREG S.A.
WAR:PTG
|
-0.154x |
Annual Cash Flow Conversion Efficiency for CryoCell International Inc (1996–2024)
The table below shows the annual cash flow conversion efficiency of CryoCell International Inc from 1996 to 2024. Review free cash flow generation of CryoCell International Inc to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-11-30 | $-13.22 Million | $6.01 Million | -0.455x | +43.75% |
| 2023-11-30 | $-11.03 Million | $8.92 Million | -0.809x | +85.62% |
| 2022-11-30 | $-1.52 Million | $8.57 Million | -5.624x | -396.90% |
| 2021-11-30 | $4.18 Million | $7.93 Million | 1.894x | +159.63% |
| 2020-11-30 | $-2.67 Million | $8.47 Million | -3.177x | -249.31% |
| 2019-11-30 | $-6.95 Million | $6.32 Million | -0.909x | -51.90% |
| 2018-11-30 | $-8.91 Million | $5.33 Million | -0.599x | -30.91% |
| 2017-11-30 | $-12.50 Million | $5.72 Million | -0.457x | -41.33% |
| 2016-11-30 | $-15.41 Million | $4.99 Million | -0.324x | +66.89% |
| 2015-11-30 | $-4.96 Million | $4.85 Million | -0.977x | -574.23% |
| 2014-11-30 | $-10.73 Million | $1.55 Million | -0.145x | -63.43% |
| 2013-11-30 | $-9.27 Million | $821.98K | -0.089x | -121.12% |
| 2012-11-30 | $-9.00 Million | $360.90K | -0.040x | +87.95% |
| 2011-11-30 | $-2.46 Million | $819.12K | -0.333x | +77.92% |
| 2010-11-30 | $-1.55 Million | $2.34 Million | -1.508x | -108.48% |
| 2009-11-30 | $-5.18 Million | $3.75 Million | -0.723x | -721.95% |
| 2008-11-30 | $-6.98 Million | $614.16K | -0.088x | -117.04% |
| 2007-11-30 | $-6.59 Million | $-3.40 Million | 0.517x | +216.84% |
| 2006-11-30 | $-2.09 Million | $924.90K | -0.442x | -105.42% |
| 2005-11-30 | $394.56K | $3.22 Million | 8.157x | +246.69% |
| 2004-11-30 | $-835.75K | $4.65 Million | -5.561x | -1359.26% |
| 2003-11-30 | $-3.79 Million | $-1.67 Million | 0.442x | +2061.91% |
| 2002-11-30 | $9.87 Million | $201.56K | 0.020x | -76.42% |
| 2001-11-30 | $14.52 Million | $1.26 Million | 0.087x | +139.99% |
| 2000-11-30 | $6.64 Million | $239.53K | 0.036x | +136.10% |
| 1999-11-30 | $5.00 Million | $-500.00K | -0.100x | +85.63% |
| 1998-11-30 | $2.30 Million | $-1.60 Million | -0.696x | -115.65% |
| 1997-11-30 | $3.10 Million | $-1.00 Million | -0.323x | -199.46% |
| 1996-11-30 | $3.70 Million | $1.20 Million | 0.324x | -- |
About CryoCell International Inc
Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manu… Read more